Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Acta Oncologica (Stockholm, Sweden)
|
January 3, 2025
Real-world data on utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer: impact on surgical complications and oncological efficacy
Hege S Haugnes, Hakon Kjaeve, Eivind Bjerkaas, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 5, 2025
Key Updates in Testicular Cancer: Optimizing Survivorship and Survival
Aditya Bagrodia, Hege Sagstuen Haugnes, Ragnhild Hellesnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2022
Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors
Sophie D Fosså, Alv A Dahl, Lene Thorsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 28, 2020
Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study
Ragnhild Hellesnes, Tor Åge Myklebust, Roy M Bremnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 13, 2021
Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort
Ragnhild Hellesnes, Tor Åge Myklebust, Sophie D Fosså, et al.
International Journal of Cancer
|
October 10, 2019
Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era
Ragnhild Hellesnes, Øivind Kvammen, Tor Å Myklebust, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 19, 2018
Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors
Line V Hjelle, Per O M Gundersen, Ragnhild Hellesnes, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Acta Oncologica (Stockholm, Sweden)
|
January 3, 2025
Real-world data on utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer: impact on surgical complications and oncological efficacy
Hege S Haugnes, Hakon Kjaeve, Eivind Bjerkaas, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 5, 2025
Key Updates in Testicular Cancer: Optimizing Survivorship and Survival
Aditya Bagrodia, Hege Sagstuen Haugnes, Ragnhild Hellesnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2022
Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors
Sophie D Fosså, Alv A Dahl, Lene Thorsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 28, 2020
Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study
Ragnhild Hellesnes, Tor Åge Myklebust, Roy M Bremnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 13, 2021
Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort
Ragnhild Hellesnes, Tor Åge Myklebust, Sophie D Fosså, et al.
International Journal of Cancer
|
October 10, 2019
Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era
Ragnhild Hellesnes, Øivind Kvammen, Tor Å Myklebust, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 19, 2018
Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors
Line V Hjelle, Per O M Gundersen, Ragnhild Hellesnes, et al.
Page
of 1